Comparing the clinical impact of pancreatic cyst surveillance programs: A trial of the ECOG-ACRIN cancer research group (EA2185)

The optimal surveillance strategy for pancreatic cysts, which occur in up to 20% of the adult population, is ill defined. The risk of malignant degeneration of these cysts is low, however the morbidity and mortality associated with pancreatic cancer are high. Two clinical surveillance guidelines are in regular use. Both the Fukuoka and American Gastroenterological Association (AGA) guidelines rely on radiographic and endoscopic imaging. They differ primarily in their recommended frequencies of interval surveillance imaging.

Source: Contemporary Clinical Trials - September 9, 2020 Category: Radiology Authors: David S. Weinberg, Constantine Gatsonis, Herbert J. Zeh, Ruth C. Carlos, Peter J. O'Dwyer, on behalf of the EA2185 Team Source Type: research